Literature DB >> 21886060

Effect of hepatitis C virus infection on the left ventricular systolic and diastolic functions.

Mehmet Demir1, Canan Demir.   

Abstract

BACKGROUND: Hepatitis secondary to infection with the hepatitis C virus (HCV) is one of the most common causes of viral hepatitis worldwide. Multiple extrahepatic manifestations of HCV infection have been recognized. Dilated and hypertrophic cardiomyopathy associated with HCV infection have been recently described in the literature; however, the effect of HCV infection on the left ventricular systolic and diastolic functions is unknown. Therefore, in this study we aimed to examine left ventricular systolic and diastolic functions in HCV patients. METHODS AND
RESULTS: The study included 50 anti-HCV positive patients and 50 persons for control groups. We performed transthorasic echocardiography and P-wave analysis on all participants. We compared left ventricle diastolic parameters, left ventricle ejection fraction, and P-wave dispersion (Pd) between these two groups. In the group with anti-HCV positivity, the ratio of E/A was found to be lower (1.2 ± 0.7 and 1.37 ± 0.6, P = 0.003); the ratio of E/Em was found to be higher (7.6 ± 1.51 and 6.8 ± 1.72, P = 0.0001). Maximum P-wave duration (Pmax) and Pd were higher in the patient group (99.3 ± 8 and 82.4 ± 7.8, P = 0.004; 44.1 ± 0.9 and 25.3 ± 1.5, P = 0.001). No other statistically significant difference was found between the two groups with regard to the left ventricle systolic and diastolic parameters.
CONCLUSION: Our findings show that HCV infection may be associated with left ventricular systolic and diastolic dysfunction and cardiac arrhythmias.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21886060     DOI: 10.1097/SMJ.0b013e31822462e2

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  6 in total

1.  Effect of hepatitis C virus infection on the right ventricular functions, pulmonary arterypressure and pulmonary vascular resistance.

Authors:  Canan Demir; Mehmet Demir
Journal:  Int J Clin Exp Med       Date:  2014-08-15

2.  Cardiovascular risk assessment by electrocardiographic Holter monitoring in patients with chronic hepatitis C.

Authors:  Adam R Poliwczak; Jolanta Białkowska; Joanna Woźny; Marzena Koziróg; Agnieszka Bała; Maciej Jabłkowski
Journal:  Arch Med Sci       Date:  2020-07-15       Impact factor: 3.318

3.  Cardiac remodelling identified by cardiovascular magnetic resonance in patients with hepatitis C infection and liver disease.

Authors:  Phillip J Ngu; Michelle Butler; Alan Pham; Stuart K Roberts; Andrew J Taylor
Journal:  Int J Cardiovasc Imaging       Date:  2015-12-15       Impact factor: 2.357

4.  Effect of hepatitis B virus infection on right and left ventricular functions.

Authors:  Mehmet Demir; Canan Demir
Journal:  Med Sci Monit       Date:  2012-09

5.  Internal driving factors leading to extrahepatic manifestation of the hepatitis C virus infection.

Authors:  Zhou-Yi Wu; Jian-Rui Li; Meng-Hao Huang; Jun-Jun Cheng; Hu Li; Jin-Hua Chen; Xiao-Qin Lv; Zong-Gen Peng; Jian-Dong Jiang
Journal:  Int J Mol Med       Date:  2017-10-05       Impact factor: 4.101

6.  Some considerations about cardiac toxicity of combination therapy for chronic hepatitis C.

Authors:  Reza Karbasi-Afshar; Amin Saburi
Journal:  Hepat Mon       Date:  2013-05-14       Impact factor: 0.660

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.